- Home
- AEG vs ASND Comparison
AEG vs ASND Comparison
Compare AEG & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEG
- ASND
- Stock Information
- Founded
- AEG 1983
- ASND 2006
- Country
- AEG Netherlands
- ASND Denmark
- Employees
- AEG N/A
- ASND N/A
- Industry
- AEG Life Insurance
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- AEG Finance
- ASND Health Care
- Exchange
- AEG Nasdaq
- ASND Nasdaq
- Market Cap
- AEG 11.0B
- ASND 10.6B
- IPO Year
- AEG N/A
- ASND 2015
- Fundamental
- Price
- AEG $7.28
- ASND $174.18
- Analyst Decision
- AEG Strong Buy
- ASND Strong Buy
- Analyst Count
- AEG 1
- ASND 17
- Target Price
- AEG N/A
- ASND $220.06
- AVG Volume (30 Days)
- AEG 9.1M
- ASND 399.8K
- Earning Date
- AEG 01-01-0001
- ASND 09-02-2025
- Dividend Yield
- AEG 2.56%
- ASND N/A
- EPS Growth
- AEG N/A
- ASND N/A
- EPS
- AEG 0.39
- ASND N/A
- Revenue
- AEG $13,292,266,284.00
- ASND $398,509,511.00
- Revenue This Year
- AEG N/A
- ASND $75.05
- Revenue Next Year
- AEG $2.01
- ASND $78.14
- P/E Ratio
- AEG $17.68
- ASND N/A
- Revenue Growth
- AEG N/A
- ASND 12.06
- 52 Week Low
- AEG $5.42
- ASND $111.09
- 52 Week High
- AEG $7.32
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- AEG 62.17
- ASND 55.04
- Support Level
- AEG $7.15
- ASND $167.52
- Resistance Level
- AEG $7.31
- ASND $180.78
- Average True Range (ATR)
- AEG 0.08
- ASND 5.72
- MACD
- AEG 0.03
- ASND -0.62
- Stochastic Oscillator
- AEG 94.12
- ASND 52.65
About AEG Aegon Ltd. New York Registry Shares
Aegon is a life insurance and long-term savings business listed in the Netherlands. It listed on the Amsterdam Stock Exchange in the 1980s and now has mature operations in the United States, United Kingdom, and four growth markets of Brazil, China, Portugal, and Spain. Over recent years, Aegon has been moving through an extensive transformation program where management has sought to divest noncore operations and improve the risk profile of the business. Financial assets are the parts of the group that are now being run off. Aegon is looking to cycle out of capital-consumptive and volatile-earnings products and recycle funds into capital-light and more predictable strategic businesses.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.